Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma.

Modak S, Kushner BH, Kramer K, Vickers A, Cheung IY, Cheung NK.

Oncoimmunology. 2013 Mar 1;2(3):e23402.

PMID:
23802080
[PubMed]
Free PMC Article
2.

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

Cheung NK, Modak S.

Clin Cancer Res. 2002 May;8(5):1217-23.

PMID:
12006541
[PubMed - indexed for MEDLINE]
Free Article
3.

Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.

Cheung NK, Cheung IY, Kramer K, Modak S, Kuk D, Pandit-Taskar N, Chamberlain E, Ostrovnaya I, Kushner BH.

Int J Cancer. 2014 Nov 1;135(9):2199-205. doi: 10.1002/ijc.28851. Epub 2014 Apr 3.

PMID:
24644014
[PubMed - indexed for MEDLINE]
4.

Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

Kushner BH, Kramer K, Modak S, Cheung NK.

J Clin Oncol. 2011 Mar 20;29(9):1168-74. doi: 10.1200/JCO.2010.28.3317. Epub 2011 Feb 22.

PMID:
21343563
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Kushner BH, Modak S, Basu EM, Roberts SS, Kramer K, Cheung NK.

Cancer. 2013 Aug 1;119(15):2789-95. doi: 10.1002/cncr.28137. Epub 2013 Apr 30.

PMID:
23633099
[PubMed - indexed for MEDLINE]
6.

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

Cheung NK, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA.

J Clin Oncol. 1987 Sep;5(9):1430-40.

PMID:
3625258
[PubMed - indexed for MEDLINE]
7.

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.

Cheung NK, Kushner BH, Cheung IY, Kramer K, Canete A, Gerald W, Bonilla MA, Finn R, Yeh SJ, Larson SM.

J Clin Oncol. 1998 Sep;16(9):3053-60.

PMID:
9738575
[PubMed - indexed for MEDLINE]
8.

Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.

Navid F, Sondel PM, Barfield R, Shulkin BL, Kaufman RA, Allay JA, Gan J, Hutson P, Seo S, Kim K, Goldberg J, Hank JA, Billups CA, Wu J, Furman WL, McGregor LM, Otto M, Gillies SD, Handgretinger R, Santana VM.

J Clin Oncol. 2014 May 10;32(14):1445-52. doi: 10.1200/JCO.2013.50.4423. Epub 2014 Apr 7.

PMID:
24711551
[PubMed - indexed for MEDLINE]
9.

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.

Cheung NK, Cheung IY, Kushner BH, Ostrovnaya I, Chamberlain E, Kramer K, Modak S.

J Clin Oncol. 2012 Sep 10;30(26):3264-70. doi: 10.1200/JCO.2011.41.3807. Epub 2012 Aug 6.

PMID:
22869886
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.

Kushner BH, Kramer K, Cheung NK.

J Clin Oncol. 2001 Nov 15;19(22):4189-94.

PMID:
11709561
[PubMed - indexed for MEDLINE]
11.

High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.

Kushner BH, Cheung IY, Kramer K, Modak S, Cheung NK.

Pediatr Blood Cancer. 2007 Apr;48(4):430-4.

PMID:
16421906
[PubMed - indexed for MEDLINE]
12.

Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.

Cheung IY, Lo Piccolo MS, Collins N, Kushner BH, Cheung NK.

Cancer. 2002 Jun 1;94(11):3042-8.

PMID:
12115395
[PubMed - indexed for MEDLINE]
Free Article
13.

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.

Cheung IY, Lo Piccolo MS, Kushner BH, Kramer K, Cheung NK.

J Clin Oncol. 2003 Mar 15;21(6):1087-93.

PMID:
12637475
[PubMed - indexed for MEDLINE]
14.

Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.

Parsons K, Bernhardt B, Strickland B.

Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5. Review.

PMID:
23386066
[PubMed - indexed for MEDLINE]
15.

Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.

Bergman I, Arbit E, Rosenblum M, Larson SM, Heller G, Cheung NK.

J Neurooncol. 1993 Mar;15(3):235-42.

PMID:
8360709
[PubMed - indexed for MEDLINE]
16.

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.

Kramer K, Gerald WL, Kushner BH, Larson SM, Hameed M, Cheung NK.

Clin Cancer Res. 1998 Sep;4(9):2135-9.

PMID:
9748131
[PubMed - indexed for MEDLINE]
Free Article
17.

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.

Kushner BH, Cheung NK.

Blood. 1989 May 15;73(7):1936-41.

PMID:
2653466
[PubMed - indexed for MEDLINE]
Free Article
18.

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.

Kramer K, Gerald WL, Kushner BH, Larson SM, Hameed M, Cheung NK.

Med Pediatr Oncol. 2001 Jan;36(1):194-6.

PMID:
11464881
[PubMed - indexed for MEDLINE]
19.

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.

Cheung NK, Canete A, Cheung IY, Ye JN, Liu C.

Int J Cancer. 1993 May 28;54(3):499-505.

PMID:
8509225
[PubMed - indexed for MEDLINE]
20.

A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.

Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5842-52. Review.

PMID:
14676105
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk